1. Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis. (22nd February 2021) Authors: Graier, T.; Salmhofer, W.; Jonak, C.; Weger, W.; Kölli, C.; Gruber, B.; Sator, P.G.; Prillinger, K.; Mlynek, A.; Schütz‐Bergmayr, M.; Richter, L.; Ratzinger, G.; Painsi, C.; Selhofer, S.; Häring, N.; Wippel‐Slupetzky, K.; Skvara, H.; Trattner, H.; Tanew, A.; Inzinger, M. Journal: British journal of dermatology Issue: Volume 184:Number 6(2021) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis*. (1st June 2021) Authors: Graier, T.; Salmhofer, W.; Jonak, C.; Weger, W.; Kölli, C.; Gruber, B.; Sator, P.G.; Prillinger, K.; Mlynek, A.; Schütz‐Bergmayr, M.; Richter, L.; Ratzinger, G.; Painsi, C.; Selhofer, S.; Häring, N.; Wippel‐Slupetzky, K.; Skvara, H.; Trattner, H.; Tanew, A.; Inzinger, M. Journal: British journal of dermatology Issue: Volume 184:Number 6(2021) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis. (1st June 2021) Authors: Graier, T.; Salmhofer, W.; Jonak, C.; Weger, W.; Kölli, C.; Gruber, B.; Sator, P.G.; Prillinger, K.; Mlynek, A.; Schütz‐Bergmayr, M.; Richter, L.; Ratzinger, G.; Painsi, C.; Selhofer, S.; Häring, N.; Wippel‐Slupetzky, K.; Skvara, H.; Trattner, H.; Tanew, A.; Inzinger, M. Journal: British journal of dermatology Issue: Volume 184:Number 6(2021) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗